Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Post-sensitization administration of non-digestible oligosaccharides and Bifidobacterium breve M-16V reduces allergic symptoms in mice.

van Esch BC, Abbring S, Diks MA, Dingjan GM, Harthoorn LF, Vos AP, Garssen J.

Immun Inflamm Dis. 2016 Mar 24;4(2):155-165. eCollection 2016 Jun.

2.

Post-sensitization administration of non-digestible oligosaccharides and Bifidobacterium breve M-16V reduces allergic symptoms in mice.

van Esch BCAM, Abbring S, Diks MAP, Dingjan GM, Harthoorn LF, Vos AP, Garssen J.

Immun Inflamm Dis. 2016 Jun;4(2):155-165. doi: 10.1002/iid3.101. Epub 2016 Mar 24.

3.

Increased intake of vegetable oil rich in n-6 PUFA enhances allergic symptoms and prevents oral tolerance induction in whey-allergic mice.

van den Elsen LW, van Esch BC, Dingjan GM, Hofman GA, Garssen J, Willemsen LE.

Br J Nutr. 2015 Aug 28;114(4):577-85. doi: 10.1017/S0007114515002007. Epub 2015 Jul 16.

PMID:
26179875
4.

Effects of short-chain galacto- and long-chain fructo-oligosaccharides on systemic and local immune status during pregnancy.

van Vlies N, Hogenkamp A, Thijssen S, Dingjan GM, Knipping K, Garssen J, Knippels LM.

J Reprod Immunol. 2012 Jun;94(2):161-8. doi: 10.1016/j.jri.2012.02.007. Epub 2012 Mar 30.

PMID:
22464279
5.

Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice.

Kil LP, de Bruijn MJ, van Nimwegen M, Corneth OB, van Hamburg JP, Dingjan GM, Thaiss F, Rimmelzwaan GF, Elewaut D, Delsing D, van Loo PF, Hendriks RW.

Blood. 2012 Apr 19;119(16):3744-56. doi: 10.1182/blood-2011-12-397919. Epub 2012 Mar 1.

PMID:
22383797
6.

The neonatal Fc receptor is expressed by human retinal pigment epithelial cells and is downregulated by tumour necrosis factor-alpha.

van Bilsen K, van Hagen PM, Bastiaans J, van Meurs JC, Missotten T, Kuijpers RW, Hooijkaas H, Dingjan GM, Baarsma GS, Dik WA.

Br J Ophthalmol. 2011 Jun;95(6):864-8. doi: 10.1136/bjo.2010.187930. Epub 2011 Jan 7.

PMID:
21216798
7.

Pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity.

Ta VB, de Haan AB, de Bruijn MJ, Dingjan GM, Hendriks RW.

Leukemia. 2011 Jan;25(1):48-56. doi: 10.1038/leu.2010.246. Epub 2010 Oct 29.

PMID:
21030983
8.

The β-human chorionic gonadotropin-related peptide LQGV reduces mortality and inflammation in a murine polymicrobial sepsis model.

van den Berg JW, Dik WA, van der Zee M, Bonthuis F, van Holten-Neelen C, Dingjan GM, Benner R, Ijzermans JN, Khan NA, de Bruin RW.

Crit Care Med. 2011 Jan;39(1):126-34. doi: 10.1097/CCM.0b013e3181fa3a93.

PMID:
20890188
9.

Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells.

Kersseboom R, Kil L, Flierman R, van der Zee M, Dingjan GM, Middendorp S, Maas A, Hendriks RW.

Eur J Immunol. 2010 Sep;40(9):2643-54. doi: 10.1002/eji.201040521.

10.

Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.

van Steensel L, Paridaens D, Dingjan GM, van Daele PL, van Hagen PM, Kuijpers RW, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA.

Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1002-7. doi: 10.1167/iovs.09-4338. Epub 2009 Sep 24.

PMID:
19797221
11.

Cytokines in the colon of a patient with Behçet's disease.

Kappen JH, Dik WA, Dingjan GM, van Daele PL, Hooijkaas H, van Hagen PM, van Laar JA.

Arthritis Res Ther. 2009;11(4):412. doi: 10.1186/ar2784. Epub 2009 Aug 27. No abstract available.

12.

Gene expression profiling in mice with enforced Gata3 expression reveals putative targets of Gata3 in double positive thymocytes.

van Hamburg JP, de Bruijn MJ, Ribeiro de Almeida C, Dingjan GM, Hendriks RW.

Mol Immunol. 2009 Oct;46(16):3251-60. doi: 10.1016/j.molimm.2009.08.004. Epub 2009 Sep 2.

PMID:
19729201
13.

Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.

van Steensel L, Paridaens D, Schrijver B, Dingjan GM, van Daele PL, van Hagen PM, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA.

Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3091-8. doi: 10.1167/iovs.08-2443. Epub 2009 Feb 21.

PMID:
19234339
14.

Critical role for the transcription regulator CCCTC-binding factor in the control of Th2 cytokine expression.

Ribeiro de Almeida C, Heath H, Krpic S, Dingjan GM, van Hamburg JP, Bergen I, van de Nobelen S, Sleutels F, Grosveld F, Galjart N, Hendriks RW.

J Immunol. 2009 Jan 15;182(2):999-1010.

15.

Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.

van Hamburg JP, de Bruijn MJ, Dingjan GM, Beverloo HB, Diepstraten H, Ling KW, Hendriks RW.

Mol Immunol. 2008 Jun;45(11):3085-95. doi: 10.1016/j.molimm.2008.03.018. Epub 2008 May 8.

PMID:
18471881
16.
17.

GATA3 controls the expression of CD5 and the T cell receptor during CD4 T cell lineage development.

Ling KW, van Hamburg JP, de Bruijn MJ, Kurek D, Dingjan GM, Hendriks RW.

Eur J Immunol. 2007 Apr;37(4):1043-52.

18.

Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity.

Middendorp S, Zijlstra AJ, Kersseboom R, Dingjan GM, Jumaa H, Hendriks RW.

Blood. 2005 Jan 1;105(1):259-65. Epub 2004 Aug 26.

PMID:
15331445
19.

Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity.

Middendorp S, Dingjan GM, Maas A, Dahlenborg K, Hendriks RW.

J Immunol. 2003 Dec 1;171(11):5988-96.

20.

Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells.

Kersseboom R, Middendorp S, Dingjan GM, Dahlenborg K, Reth M, Jumaa H, Hendriks RW.

J Exp Med. 2003 Jul 7;198(1):91-8. Epub 2003 Jun 30.

21.

Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice.

Middendorp S, Dingjan GM, Hendriks RW.

J Immunol. 2002 Mar 15;168(6):2695-703.

22.
23.

Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo.

Nawijn MC, Dingjan GM, Ferreira R, Lambrecht BN, Karis A, Grosveld F, Savelkoul H, Hendriks RW.

J Immunol. 2001 Jul 15;167(2):724-32.

24.

Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice.

Nawijn MC, Ferreira R, Dingjan GM, Kahre O, Drabek D, Karis A, Grosveld F, Hendriks RW.

J Immunol. 2001 Jul 15;167(2):715-23.

25.

Bruton's tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse.

Dingjan GM, Middendorp S, Dahlenborg K, Maas A, Grosveld F, Hendriks RW.

J Exp Med. 2001 May 21;193(10):1169-78.

27.

Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.

Dingjan GM, Maas A, Nawijn MC, Smit L, Voerman JS, Grosveld F, Hendriks RW.

EMBO J. 1998 Sep 15;17(18):5309-20.

28.

The X-linked immunodeficiency defect in the mouse is corrected by expression of human Bruton's tyrosine kinase from a yeast artificial chromosome transgene.

Maas A, Dingjan GM, Savelkoul HF, Kinnon C, Grosveld F, Hendriks RW.

Eur J Immunol. 1997 Sep;27(9):2180-7.

PMID:
9341757
29.

Expression of Bruton's tyrosine kinase in B lymphoblastoid cell lines from X-linked agammaglobulinaemia patients.

De Weers M, Dingjan GM, Brouns GS, Kraakman ME, Mensink RG, Lovering RC, Schuurman RK, Borst J, Hendriks RW.

Clin Exp Immunol. 1997 Feb;107(2):235-40.

30.
31.

Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage.

Hendriks RW, de Bruijn MF, Maas A, Dingjan GM, Karis A, Grosveld F.

EMBO J. 1996 Sep 16;15(18):4862-72.

32.

The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease.

Kremer HP, Roos RA, Dingjan GM, Bots GT, Bruyn GW, Hofman MA.

Neurosci Lett. 1991 Oct 28;132(1):101-4.

PMID:
1838577
33.

Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi.

Ruiter DJ, Dingjan GM, Steijlen PM, van Beveren-Hooyer M, de Graaff-Reitsma C, Bergman W, van Muijen GN, Warnaar SO.

J Invest Dermatol. 1985 Jul;85(1):4-8.

34.

Monoclonal antibody PAL-E specific for endothelium.

Schlingemann RO, Dingjan GM, Emeis JJ, Blok J, Warnaar SO, Ruiter DJ.

Lab Invest. 1985 Jan;52(1):71-6.

PMID:
3880842

Supplemental Content

Loading ...
Support Center